Moderna's coronavirus vaccine triggers immune response, deemed safe to move to Phase 3 testing
The first coronavirus vaccine tested in humans in the U.S. triggered an immune response and is moving to Phase 3 trials. Dr. David Agus explains what this means for the fight against the virus.